EX-2.1
from S-4/A
106 pages
Agreement and Plan of Merger by and Among Scilex Holding Company, Sigma Merger Sub, Inc., Semnur Pharmaceuticals, Inc., Fortis Advisors LLC, Solely as the Equityholders’ Representative And, Solely With Respect to Section 1.8(a), Section 3.11 and Article X, Sorrento Therapeutics, Inc. Dated as of March 18, 2019
12/34/56
EX-2.1
from S-4
106 pages
Agreement and Plan of Merger by and Among Scilex Holding Company, Sigma Merger Sub, Inc., Semnur Pharmaceuticals, Inc., Fortis Advisors LLC, Solely as the Equityholders’ Representative And, Solely With Respect to Section 1.8(a), Section 3.11 and Article X, Sorrento Therapeutics, Inc. Dated as of March 18, 2019
12/34/56
EX-2.1
from 425
450 pages
Agreement and Plan of Merger by and Among Denali Spac Holdco, Inc. Denali Capital Acquisition Corp. Denali Spac Merger Sub, Inc. Longevity Biomedical, Inc. Longevity Merger Sub, Inc. and Bradford A. Zakes, in the Capacity as Seller Representative Dated as of January 25, 2023
12/34/56
EX-2.1
from 8-K/A
450 pages
Agreement and Plan of Merger by and Among Denali Spac Holdco, Inc. Denali Capital Acquisition Corp. Denali Spac Merger Sub, Inc. Longevity Biomedical, Inc. Longevity Merger Sub, Inc. and Bradford A. Zakes, in the Capacity as Seller Representative Dated as of January 25, 2023
12/34/56